Literature DB >> 1911553

Structure, function and flexibility of human lactoferrin.

E N Baker1, B F Anderson, H M Baker, M Haridas, G B Jameson, G E Norris, S V Rumball, C A Smith.   

Abstract

X-ray structure analyses of four different forms of human lactoferrin (diferric, dicupric, an oxalate-substituted dicupric, and apo-lactoferrin), and of bovine diferric lactoferrin, have revealed various ways in which the protein structure adapts to different structural and functional states. Comparison of diferric and dicupric lactoferrins has shown that different metals can, through slight variations in the metal position, have different stereochemistries and anion coordination without any significant change in the protein structure. Substitution of oxalate for carbonate, as seen in the structure of a hybrid dicupric complex with oxalate in one site and carbonate in the other, shows that larger anions can be accommodated by small side-chain movements in the binding site. The multidomain nature of lactoferrin also allows rigid body movements. Comparison of human and bovine lactoferrins, and of these with rabbit serum transferrin, shows that the relative orientations of the two lobes in each molecule can vary; these variations may contribute to differences in their binding properties. The structure of apo-lactoferrin demonstrates the importance of large-scale domain movements for metal binding and release and suggests that in solution an equilibrium exists between open and closed forms, with the open form being the active binding species. These structural forms are shown to be similar to those seen for bacterial periplasmic binding proteins, and lead to a common model for the various steps in the binding process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911553     DOI: 10.1016/0141-8130(91)90036-t

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  10 in total

1.  Spectrophotometric titration with cobalt(III) for the determination of accurate absorption coefficients of transferrins.

Authors:  Q Y He; A B Mason; R C Woodworth
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

2.  Evaluation of the bioactivity of recombinant human lactoferrins toward murine osteoblast-like cells for bone tissue engineering.

Authors:  Ashley A Amini; Lakshmi S Nair
Journal:  Tissue Eng Part A       Date:  2013-02-19       Impact factor: 3.845

3.  Association of the two lobes of ovotransferrin is a prerequisite for receptor recognition. Studies with recombinant ovotransferrins.

Authors:  A B Mason; R C Woodworth; R W Oliver; B N Green; L N Lin; J F Brandts; K J Savage; B M Tam; R T MacGillivray
Journal:  Biochem J       Date:  1996-10-15       Impact factor: 3.857

4.  Receptor recognition sites reside in both lobes of human serum transferrin.

Authors:  A B Mason; B M Tam; R C Woodworth; R W Oliver; B N Green; L N Lin; J F Brandts; K J Savage; J A Lineback; R T MacGillivray
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

5.  Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment.

Authors:  K Yamauchi; M Tomita; T J Giehl; R T Ellison
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  A computational study of the open and closed forms of the N-lobe human serum transferrin apoprotein.

Authors:  David Rinaldo; Martin J Field
Journal:  Biophys J       Date:  2003-12       Impact factor: 4.033

7.  Structure and domain dynamics of human lactoferrin in solution and the influence of Fe(III)-ion ligand binding.

Authors:  Clemens Sill; Ralf Biehl; Bernd Hoffmann; Aurel Radulescu; Marie-Sousai Appavou; Bela Farago; Rudolf Merkel; Dieter Richter
Journal:  BMC Biophys       Date:  2016-11-04       Impact factor: 4.778

8.  Cross-link guided molecular modeling with ROSETTA.

Authors:  Abdullah Kahraman; Franz Herzog; Alexander Leitner; George Rosenberger; Ruedi Aebersold; Lars Malmström
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

9.  Regulation of Iron Homeostasis through Parkin-Mediated Lactoferrin Ubiquitylation.

Authors:  Ankur A Gholkar; Stefan Schmollinger; Erick F Velasquez; Yu-Chen Lo; Whitaker Cohn; Joseph Capri; Harish Dharmarajan; William J Deardorff; Lucy W Gao; Mai Abdusamad; Julian P Whitelegge; Jorge Z Torres
Journal:  Biochemistry       Date:  2020-08-06       Impact factor: 3.321

Review 10.  Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?

Authors:  Klas Norrby
Journal:  APMIS       Date:  2013-10-26       Impact factor: 3.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.